---
figid: PMC9467758__OMCL2022-9029544.006
pmcid: PMC9467758
image_filename: OMCL2022-9029544.006.jpg
figure_link: /pmc/articles/PMC9467758/figure/fig6/
number: Figure 6
figure_title: ''
caption: CBR-5884 exerts anti-tumor effect in vivo. (a) Tumor xenograft, (b) tumor
  volume, (c) tumor weight, (d) related protein level via WB, and (e) HE staining,
  PHGDH, and Ki67 expression level via IHC in two groups.
article_title: PHGDH Inhibitor CBR-5884 Inhibits Epithelial Ovarian Cancer Progression
  via ROS/Wnt/Î²-Catenin Pathway and Plays a Synergistic Role with PARP Inhibitor Olaparib.
citation: Xiaocui Zhang, et al. Oxid Med Cell Longev. 2022;2022:9029544.
year: '2022'

doi: 10.1155/2022/9029544
journal_title: Oxidative Medicine and Cellular Longevity
journal_nlm_ta: Oxid Med Cell Longev
publisher_name: Hindawi

keywords:
---
